TNFSF11 and osteopetrosis: In contrast, deleting Lyn increases receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastogenesis, resulting in osteopenia rather than osteopetrosis, and has little effect on the activity of mature osteoclasts (8, 9).